Biotinidase Serum




Test Mnemonic

BIOTIN

CPT Codes

  • 82261 - QTY (1)

LOINC ®

1982-8

Performing Laboratory

Cleveland Clinic Laboratories

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumSST (Gold) Centrifuge, aliquot and freeze ASAP.Centrifuge and remove serum ASAP or within 30 minutes of collection. Freeze immediately. Transport frozen specimen to testing laboratory.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLPlasmaGreen LiHep Nogel Centrifuge, aliquot and freeze ASAP.Centrifuge and remove plasma ASAP or within 30 minutes of collection. Freeze immediately. Transport frozen specimen to testing laboratory.
1 mLSerumRed Plain Centrifuge, aliquot and freeze ASAP.Centrifuge and remove serum from clot ASAP and then freeze immediately. Transport frozen to testing laboratory.
1 mLPlasmaLithium heparin PST (Lt. Green) Centrifuge, aliquot and freeze ASAP.Centrifuge and remove plasma ASAP or within 30 minutes of collection. Freeze immediately. Transport frozen specimen to testing laboratory.
1 mLPlasmaSodium heparin (Green) Centrifuge, aliquot and freeze ASAP.Centrifuge and remove plasma ASAP or within 30 minutes of collection. Freeze immediately. Transport frozen specimen to testing laboratory.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
Ambient 4 hours, after separation from cells
Refrigerated 4 hours, after separation from cells
Frozen7 days, after separation from cells, at < -20 degrees Celsius

Days Performed

Varies

Turnaround Time

1 - 7 days

Methodology

Name Description
Colorimetry 

Reference Range

Biotinidase Serum
Sex Age From Age To Type Range Range Unit
   Years99 YearsNormal4.4 - 12.0U/L

Special Info

Centrifuge, remove from cells, aliquot and freeze ASAP. Transport frozen.

Clinical Info

Evaluation of individuals with: 1) unexplained seizures; 2) unexplained ataxia or marked clumsiness; 3) unexplained hearing loss, especially if on a sensorineural basis and especially if accompanied by neurological abnormalities and/or dermatitis; 4) unexplained dermatitis, especially if accompanied by epilepsy, ataxia, intellectual disability and/or hearing loss. Partial deficiencies and carriers may occur at the low end of the reference range; restesting of the biotinidase activity and/or determination of possible mutations of the biotinidase gene may be indicated if the reported enzyme activity is < 4.5 U/L, depending on the enzyme level and clinical context.

Clinical Limitation

With respect to the reference interval, neonates and infants younger than 6 months of age generally have activities that are lower than those of normal adults.